Ignite Creation Date:
2025-12-24 @ 12:09 PM
Ignite Modification Date:
2025-12-31 @ 1:36 AM
Study NCT ID:
NCT03318861
Status:
TERMINATED
Last Update Posted:
2023-10-19
First Post:
2017-10-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Safety and Efficacy of KITE-585 in Participants With Relapsed/Refractory Multiple Myeloma
Sponsor:
Kite, A Gilead Company
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Relapsed/Refractory Multiple Myeloma | View |
Keywords: